Clinical Trials Logo
  1. Home
  2. Cardiovascular Outcomes
  3. NCT03206593

Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure

Ischemic Heart Failure Clinical Trial

Official title:
Fasting Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure

Clinical Trial Summary

Current prospective cohort study is to evaluate the association between fasting lipid profiles (including total cholesterol, low density lipoprotein-cholesterol, high density lipoprotein-cholesterol, triglycerides, apolipoprotein A, apolipoprotein B and lipoprotein(a)) and fasting plasma glucose at admission with cardiovascular disease outcomes (including fatal and non-fatal myocardial infarction, fatal and non-fatal ischemic stroke, re-hospitalization due to heart failure, revascularization by percutaneous coronary intervention or coronary artery bypass grafting, or cardiovascular mortality) and all-cause mortality.in patients with ischemic heart failure and left ventricular ejection fraction < 45 % evaluated by echocardiography during 12 months follow-up.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03206593
Study type Observational [Patient Registry]
Source Guangdong General Hospital
Contact
Status Recruiting
Phase N/A
Start date January 1, 2016
Completion date December 31, 2019
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02240940 - PARACHUTE China Approval Trial N/A
Completed NCT00846001 - Resynchronization Surgery Combined Unified Efficacy Phase 3
Recruiting NCT05566600 - Allogeneic iPSC-derived Cardiomyocyte Therapy in Patients With Worsening Ischemic Heart Failure Early Phase 1
Active, not recruiting NCT01961726 - Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure Phase 1/Phase 2
Terminated NCT00102128 - Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack. Phase 2
Not yet recruiting NCT03491969 - Clinical Study of Lipoic Acid on Ischemic Heart Failure Phase 4
Recruiting NCT01555320 - Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure N/A
Recruiting NCT02875639 - A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) Phase 2
Completed NCT02700880 - LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
Active, not recruiting NCT01643590 - Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. Phase 2
Active, not recruiting NCT02115568 - Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203 N/A
Enrolling by invitation NCT01709279 - Clinical Trial of Autologous Adipose Tissue Derived Stromal Cell Therapy for Ischemic Heart Failure N/A
Not yet recruiting NCT06258447 - CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction N/A